Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

US Patent 8501766 · Granted Aug 6, 2013

Estimated economic value: $113,660,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of rasagiline for the treatment of restless legs syndrome2025
Compounds for treatment of eye diseases associated with excessive vascularisatio2025
Treatment of ocular inflammatory diseases using laquinimod2023
Treatment of ocular inflammatory diseases using laquinimod2023
Compounds for treatment of eye diseases associated with excessive vascularisatio2022
Parenteral formulations of rasagiline2016
Use of laquinimod for treating Crohn's disease patients who failed first-line an2015
Use of laquinimod for treating Crohn's disease patients who failed first-line an2015
Use of laquinimod for treating Crohn's disease patients who failed first-line an2015
Use of rasagilline for the treatment of restless legs syndrome2015
Treatment of multiple sclerosis with combination of laquinimod and fingolimod2014
Treatment of multiple sclerosis with combination of laquinimod and fingolimod2014